Patents by Inventor Clarence Hull

Clarence Hull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
    Publication number: 20060194863
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: March 31, 2006
    Publication date: August 31, 2006
    Inventors: Steven Andrews, Julie Wurster, Clarence Hull
  • (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Publication number: 20060004084
    Abstract: The present invention relates to organic, molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: July 12, 2005
    Publication date: January 5, 2006
    Inventors: Steven Andrews, Xialing Guo, Zhen Zhu, Clarence Hull, Julie Wurster, Shimiao Wang, Edward Wang, Thomas Malone
  • 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Publication number: 20050228036
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: July 6, 2004
    Publication date: October 13, 2005
    Inventors: Steven Andrews, Julie Wurster, Clarence Hull